ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
Launched by CARANX MEDICAL ·
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new robotic system called TAVIPILOT, designed to help doctors place heart valves more precisely during a procedure called transcatheter aortic valve replacement (TAVR). TAVR is a treatment for people with a narrowed aortic valve, which affects blood flow from the heart. The robot allows doctors to control the placement of the new valve remotely with steady and accurate movements, aiming to improve the safety and success of the procedure.
The trial is open to adults of all genders who need TAVR using certain types of approved heart valves. If you take part, the robot will be used during your valve replacement procedure to assist the doctor, but the overall process will be similar to the standard treatment. This study is currently not recruiting participants, but it’s an important step toward making valve replacement procedures safer and more precise with the help of advanced technology.
Gender
ALL
Eligibility criteria
About Caranx Medical
Caranx Medical is a clinical trial sponsor specializing in the development and advancement of innovative medical devices and therapeutic solutions. Committed to improving patient outcomes, Caranx Medical focuses on rigorous research and collaboration with healthcare professionals to bring cutting-edge technologies from concept to clinical application. Their expertise spans various medical fields, emphasizing safety, efficacy, and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported